Pegasus Pharmaceuticals Inc.

9 articles about Pegasus Pharmaceuticals Inc.

• 

  Pharma Expansions: Beigene, Boehringer Ingelheim to Break Ground for New Faci...

  4/29/2022

  Several biopharma companies are closing out the month of April with expansions to facilities, including a $3 billion investment to develop next-generation life science ecosystems.

• Pegasus Pharmaceuticals Inc. Invited to Present at Parenteral Drug Association Fungal Contamination Control Conferences

  2/5/2013

• Pegasus Pharmaceuticals Inc. Release: Clinical Studies Completed for HeartVue's 6S Heart Screening System

  8/18/2008

• Pegasus Pharmaceuticals Inc. Files Patents on New Biological Toxic Mold Control Product, Opens Lab & Appoints Distributor for Marketing to Multi-Billion Dollar Worldwide Mold Removal Market

  3/28/2008

• Pegasus Pharmaceuticals Inc. Acquires Worldwide Marketing Rights To Effective Biological-Concept Mold Remove System -- Laboratory Tests Successfully Completed

  1/8/2007

• Pegasus Pharmaceuticals Inc. And HeartView To Market Its HeartVue 6S Screening Device In Europe

  10/30/2006

• Pegasus Pharmaceuticals Inc. And HeartView Delivers First Shipment Of 55 HeartVue 6S System Electrocardiograph Units To China

  6/27/2006

• Pegasus Pharmaceuticals Inc.' HeartVue 6S System Successfully Demonstrated To Cardiologists At American College of Cardiology 55th Scientific Session Exposition In Atlanta

  4/11/2006

• Pegasus Pharmaceuticals Inc./Heartview Signs Multi-Year Sales Agreement For China For Ground-Breaking HeartVue(TM) 6C System Technology

  2/9/2006